Protara Therapeutics, Inc. (TARA) Form 8-K — Jun 29, 2026
Protara Therapeutics announced that Leonardo Viana Nicacio, M.D., Chief Medical Officer, resigned effective June 26, 2026 to explore other opportunities. Dr.
Price after filing
1 day: -4.5%7 days: +2.0%30 days: -1.5%
Close on the filing date to close N calendar days later (from $4.00). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.